Marian University, a small Catholic college started by Franciscan nuns, next month will launch just the second medical school in Indiana. Marian President Dan Elsener is credited with pulling off the audacious move with a mix of big dreaming, careful planning, deft networking and “don’t take no for an answer” fundraising.
Fast-growing Olympia Media Group plans to hire at least 15 more employees in the next two months—the majority in the next two weeks—as it expands into new markets and rebuilds its strategy for digital content.
Hospitals already operate like for-profit businesses, but now a financial pinch is making more hospitals join their ranks. Aggressive moves by St. Vincent’s parent organization are just the beginning.
Peyton Manning’s return is pushing the value of tickets for the Broncos-at-Colts game to twice as high as any other home game. Despite that boost, the Colts are still in the NFL's bottom half in terms of ticket demand on the secondary market.
City incentives and a strong apartment market suggest Flaherty & Collins’ proposed $81 million, 28-story downtown apartment tower has a better chance of getting built than two previous attempts to redevelop the former site of Market Square Arena.
National investors have snapped up two apartment properties on the north side totaling 722 units. One complex is slated for a major rehab.
The Indianapolis-based governing body for U.S. track and field is dealing with the fallout after several high-profile stars tested positive for banned substances.
City officials will reveal the winner Tuesday morning from six teams that bid on redeveloping the downtown site. All proposed mixed-use projects, but they ranged in size from eight to 52 stories.
Dr. Bill VanNess, Indiana’s commissioner of health, asked IT developers to create a smartphone app that the state could offer to pregnant moms to educate them about infant health and help them easily schedule appointments with health care providers.
Indiana University plans to use $450,000 donated to its Indianapolis law school by former attorney William Conour to aid the clients defrauded of more than $4.5 million. Conour pleaded guilty to fraud charges Monday morning.
Under so-called reference-based benefits, insured patients would have to pay the difference between procedure prices and maximums set by their employers. Several Indiana companies are considering using the tactic.
The money from Clowes Charitable Foundation will be used to support year-round programming. October fest also benefits.
Just when you think nothing more can be said about Butler’s latest coaching departure …
Bowen Technovation President Jeff Bowen says the university unfairly favored his Florida-based competitor to install a sophisticated audio-visual system for its new planetarium, but Ball State maintains there was nothing wrong with its process for awarding the nearly $2 million contract.
WRTV-TV Channel 6 plans to begin broadcasting high school sporting events over a streaming service for smartphones and tablets.
The panel signed off Wednesday on $20 million each for the college's Anderson and Bloomington campuses and $23 million for an expansion of its Indianapolis location.
When it opens next spring, the aptly named Grand Park Sports Campus will be the largest youth sports complex of its kind in the country.
A man was shot multiple times about 4:30 p.m. Tuesday at Harmony Place Apartments in the 3900 block of North Emerson Avenue on the northeast side of Indianapolis. He was rushed to the hospital in critical condition but has since been upgraded to fair. Meanwhile, another man showed up at IU Health Methodist Hospital with a gunshot wound shortly after the other shooting was reported. He is in stable condition. Police are investigating to see if there is a connection.
Eli Lilly and Co. and Boehringer Ingelheim GmbH submitted their long-acting insulin for market approval in Europe, using the pathway for generic biotech, or biosimilar, drugs. If approved, the drug, known as insulin glargine, would finally allow Indianapolis-based Lilly to catch up with competitors Sanofi-Aventis SA and Novo Nordisk N/A in offering a once-a-day insulin for diabetics. France-based Sanofi launched the first long-acting insulin, Lantus, in 2000. Denmark-based Novo followed with its own version, Levemir, in 2004. Analysts predict sales of Lilly’s insulin glargine could top $1 billion by 2020, with some of that revenue flowing to Germany-based Boehringer.
The federal Medicare issued a mostly negative reimbursement proposal for Eli Lilly and Co.’s Amyvid imaging agent for diagnosing Alzheimer’s disease in living patients. According to Bloomberg News, the federal health plan for seniors will pay for the brain scans using Lilly’s drug only for patients participating in approved clinical studies. The $3,000 test, approved last year by the U.S. Food and Drug Administration, identifies clusters of the brain protein amyloid, which is an indicator of Alzheimer’s disease. Previously, such protein clusters could be viewed only during an autoposy. The ruling is an unexpected setback for Amyvid after European Union regulators endorsed it in January. Lilly paid $300 million in 2010 to acquire the drug and its developer, Avid Radiopharmaceuticals Inc.
The private equity firms that own Warsaw-based Biomet Inc. want their money back, according to the Financial Times. They are considering relisting the maker of orthopedic implants as a public company or selling it whole to other investors, the London newspaper reported, citing three unnamed sources. Biomet was purchased in 2007 for $11.4 billion by four private equity firms: Blackstone, KKR, TPG and the private equity arm of Goldman Sachs. The volume of hip and knee surgeries has declined since Biomet was purchased, but Biomet’s financial performance has improved, anyway. The company concluded its most recent fiscal year with $3 billion in sales and $946 million in earnings before interest, taxes, depreciation and amortization. Still, the Financial Times says current stock prices for Biomet’s competitors suggest the company may have a value of $8 billion—less than what its owners paid for it.
Major Health Partners will decide in the next six months whether to spend $23 million to maintain its existing hospital in downtown Shelbyville or spend $100 million to build a new hospital in the Intelliplex business park north of town. According to the Shelbyville News, Major Health Partners has been gradually moving to Intelliplex since 2005, opening outpatient centers focused on oncology, orthopedics, cardiology and obstetrics. Now hospital officials have drawn up tentative plans to build a 240,000-square-foot facility in Intelliplex. Major officials also said they could build a “shell” facility at Intelliplex and then add services there, while maintaining its existing, 61-bed hospital. “At some point, we will have to move, but when do we pull the trigger? That is the tough question," Major CEO Jack Horner told the Shelbyville News. Major, which is owned by the city of Shelbyville, will hold community forums before making a decision.
Indiana University Health lost a four-month battle to convince the Illinois Medicaid program to pay for a multi-organ transplant for two patients. The surgeries were expected to cost more than $1 million each, according to Crain’s Chicago Business, yet no hospitals in Illinois are capable of performing them. That’s why the two patients, a 32-year-old woman and a 67-year-old woman, came to IU Health in Indianapolis. An ethics panel called the procedures, which IU Health’s surgeons have performed 38 times, experimental. Also, the Illinois Medicaid program cited a dearth of resources in declining to cover the procedures.
The Midwestern city best known for its basketball and auto racing is gearing up for a proper game of cricket — the ball-and-bat sport most Americans know only from British films or by surfing through international sports channels.
